122 related articles for article (PubMed ID: 9208648)
1. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
Li H; Zhao SF; Wang N; Ge ZH
Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
[TBL] [Abstract][Full Text] [Related]
2. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
Reuning RH; Ashcraft SB; Wiley JN; Morrison BE
Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491
[TBL] [Abstract][Full Text] [Related]
3. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of 6beta-naltrexol after single and multiple intramuscular injections in Beagle dogs].
Yan LD; Liu J; Dong HJ; Cui MX; Yao XJ; Liu YS; Gong ZH; Gong ZH
Yao Xue Xue Bao; 2009 Jul; 44(7):722-5. PubMed ID: 19806909
[TBL] [Abstract][Full Text] [Related]
5. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
Brewer C
Addict Biol; 2002 Jul; 7(3):321-3. PubMed ID: 12126492
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone effects on male sexual behavior, corticosterone, and testosterone in stressed male rats.
Retana-Márquez S; Bonilla-Jaime H; Vázquez-Palacios G; Martínez-García R
Physiol Behav; 2009 Feb; 96(2):333-42. PubMed ID: 19027764
[TBL] [Abstract][Full Text] [Related]
7. Disposition of the opioid antagonist, LY255582, in rats and dogs.
Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone disposition in man after subcutaneous administration.
Wall ME; Perez-Reyes M; Brine DR; Cook CE
Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
[TBL] [Abstract][Full Text] [Related]
9. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of (-)-clausenamide and its major metabolite 6-hydroxyl-clausenamide in beagle dogs by HPLC/MS].
Song M; Qian W; Hang TJ; Zhang ZX
Yao Xue Xue Bao; 2005 Oct; 40(10):940-4. PubMed ID: 16408814
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and pharmacokinetics of dihydrocodeine in dog.
Konishi M; Shiono Y; Ohno M; Takahashi H; Aoki T
Xenobiotica; 1994 Jul; 24(7):591-601. PubMed ID: 7975724
[TBL] [Abstract][Full Text] [Related]
12. Sustained-release naltrexone for alcoholism treatment: a preliminary study.
Kranzler HR; Modesto-Lowe V; Nuwayser ES
Alcohol Clin Exp Res; 1998 Aug; 22(5):1074-9. PubMed ID: 9726277
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.
Valiveti S; Hammell DC; Paudel KS; Hamad MO; Crooks PA; Stinchcomb AL
J Control Release; 2005 Feb; 102(2):509-20. PubMed ID: 15653167
[TBL] [Abstract][Full Text] [Related]
14. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
Teramura T; Watanabe T; Higuchi S; Hashimoto K
Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
[TBL] [Abstract][Full Text] [Related]
16. [High performance liquid chromatographic assay for aceclofenac in plasma and its pharmacokinetics in dogs].
Liu XQ; Chen XJ; Zhao LH; Peng JH
Yao Xue Xue Bao; 1997 Jul; 32(7):546-8. PubMed ID: 11596282
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.
Valiveti S; Nalluri BN; Hammell DC; Paudel KS; Stinchcomb AL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):259-67. PubMed ID: 15380723
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
[TBL] [Abstract][Full Text] [Related]
19. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
Taylor SM; Rodgers RM; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
